US 10563260
Method of predicting a predisposition to QT prolongation
granted A61PA61P9/00
Quick answer
US patent 10563260 (Method of predicting a predisposition to QT prolongation) held by VANDA PHARMACEUTICALS INC. expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VANDA PHARMACEUTICALS INC.
- Grant date
- Tue Feb 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61P, A61P9/00